Chatham Capital Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $366,000 as of its most recent filing with the Securities and Exchange Commission. Goldman Sachs Group Inc. boosted its holdings in SPDR S&P Biotech ETF by 33.0% during the first quarter. Get SPDR S&P Biotech ETF alerts:SPDR S&P Biotech ETF Trading Up 2.2%Shares of XBI opened at $97.95 on Friday. About SPDR S&P Biotech ETFSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. Read MoreReceive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.